XML 30 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash Flows from Operating Activities:    
Net Loss $ (2,878,713) $ (2,434,753)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 421,167 367,167
Stock compensation expense 372,181 98,006
Accretion for debt discounts and issuance costs 202,690 202,725
Shares issued in exchange for services 70,000   
Loss on debt extinguishment 65,869  
Warrants issued in exchange for services 20,752 31,144
Shares issued as a conversion of payables    57,500
Changes in operating assets and liabilities:    
Accounts receivable (21,353) (1,789)
Prepaid expenses and other assets (86,085) (12,700)
Accounts payable 484,797 (167,864)
Accrued interest and other liabilities 86,860 (51)
Deferred revenue (33,967) 306,833
Deposits (2,895)   
Deferred rent (2,515) (5,287)
Net Cash Used in Operating Activities (1,301,212) (1,559,069)
Cash Flows From Investing Activities:    
Purchase of fixed assets, net of disposal    (26,488)
Payment of patent application    (5,000)
Payment of platform development costs (491,772) (378,330)
Net Cash Used in Investing Activities (491,772) (409,818)
Cash Flows from Financing Activities:    
Proceeds from issuance of debenture 175,000   
Proceeds from notes payable related parties 4,061 122,204
Repayments on notes payable related parties (252) (192,965)
Payment of convertible note, net of proceeds    (20,106)
Proceeds from issuance of convertible note payable 152,500  
Proceeds from exercise of stock options    38,532
Sale of common stock, net of issuance costs 658,700 3,573,100
Net Cash Provided by Financing Activities 990,009 3,520,765
Net (decrease) increase in cash and cash equivalents (802,975) 1,551,878
Cash and cash equivalents, beginning of period 812,064 13,724
Cash and cash equivalents, end of period 9,089 1,565,602
Supplemental Disclosure of Cash Flow Information:    
Cash paid during the period for interest 9,603 22,141
Discount cost related to issuance of debentures and warrants 110,557   
Conversion of debt to common stock shares    $ 32,006